Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia.
Anucha
A
Apisarnthanarak
Linda M
LM
Mundy
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D015780:Carbapenems / Q000008:administration & dosage* / Q000494:pharmacology; D000077726:Doripenem; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D005578:Fosfomycin / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D018440:beta-Lactam Resistance
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D005578:Fosfomycin; D000077726:Doripenem